VERA THERAPEUTICS INC. - CLASS A COMMON STOCK
43.22
03-1月-25 16:45:00
15 分の遅延
株式
+1.02
+2.42%
本日の幅
42.63 - 43.69
ISIN
N/A
ソース
NASDAQ
-
Vera Therapeutics to Host Business Update Call
17 3 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference
01 3 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
14 2 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
10 2 2022 08:46:50 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock
07 2 2022 17:24:50 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis
18 1 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 1 2022 07:30:01 提供 Nasdaq GlobeNewswire
-
17 12 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Appointment of Kimball Hall to Board of Directors
14 12 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics to Present at Upcoming Investment Conferences in November 2021
10 11 2021 16:15:01 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
10 11 2021 07:15:00 提供 Nasdaq GlobeNewswire
-
04 11 2021 16:05:01 提供 Nasdaq GlobeNewswire
-
13 10 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephropathy
09 9 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
16 8 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Vera Therapeutics Appoints Sean Grant as Chief Financial Officer
14 7 2021 07:30:00 提供 Nasdaq GlobeNewswire